ArticleEuropean radiology2025
Right ventricular myocardial infarction: cardiac magnetic resonance characteristics and prognostic implications.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association of stress hyperglycemia ratio on right ventricular dysfunction and biventricular coupling in patients with acute coronary syndrome assessed by CMR feature tracking: a cross-sectional study.Quantitative imaging in medicine and surgery · 2026Article
- Beyond ST-Segment Elevation: Recognizing the Aslanger ECG Pattern After Bentall Surgery.JACC. Case reports · 2026Article
- Predictors of right ventricular dysfunction and its clinical value after reperfusion of acute right coronary artery occlusion: a single-center retrospective analysis.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesRight ventricular myocardial infarction (RVMI) is a critical yet often underrecognized aspect of ST-segment elevation myocardial infarction (STEMI) that significantly influences clinical outcomes. Previous studies reached contradictory conclusions about the cardiac magnetic resonance (CMR) characteristics and prognostic data with RVMI. This study sought to investigate the CMR characteristics and prognostic implications of RVMI in a large cohort. MATERIALS AND
methodsThis retrospective study collected acute CMR scans from consecutive patients diagnosed with STEMI at two centers. RVMI was identified by the presence of late gadolinium enhancement and myocardial edema. The primary endpoint was a composite of major adverse cardiovascular events (MACE), including all-cause mortality, reinfarction, and hospitalization for heart failure.
resultsA total of 1005 patients (mean age 59.6 ± 11.3 years; 849 males) were included, and MACE occurred in 155 patients (15.4%) during a median of 3.6 years of follow-up. RVMI is identified in 199 patients (19.8%), who exhibit worse biventricular function and global longitudinal strain (all p < 0.001) and higher MACE incidence (22.1% vs 13.78%, p = 0.005). RVMI independently predicts worse LV global longitudinal (β = 0.931, p = 0.006) and circumferential strain (β = 0.661, p = 0.049). RVMI is strongly associated with MACE (adjusted hazard ratio [HR]: 1.45, 95% confidence interval [CI]: 1.01-2.08, p = 0.045), particularly hospitalization for heart failure (adjusted HR: 2.66, 95% CI: 1.52-4.63, p = 0.001).
conclusionRVMI aggravated the impaired LV function and was independently associated with MACE in STEMI, mainly driven by an increased risk of hospitalization for heart failure. Our findings underscore the importance of RV assessment in STEMI's long-term management and risk stratification. KEY POINTS: Question Does RVMI detected by CMR independently predict adverse outcomes and impaired cardiac function in patients with STEMI? Findings In 1005 STEMI patients, RVMI occurred in 19.8% and was independently associated with worse biventricular function and a 45% higher risk of MACE. Clinical relevance CMR identification of right ventricular involvement in STEMI patients enables better risk stratification and highlights the need for enhanced monitoring, as these patients face higher risks of heart failure hospitalization and adverse outcomes.
Indexed as
Identifiers
40515772What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.